MDAIW: the cash flow

MyFinsight

For the quarter ending 2026-03-31, MDAIW had -$3,739K decrease in cash & cash equivalents over the period.

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net income (loss)	-3,412	1,052	-3,552	-5,071
Depreciation expense	30	29	30	12
Amortization of debt issuance costs	179	171	163	120
Stock-based compensation	183	243	261	611
Amortization of right-of-use assets	147	143	141	280
Cost from issuance of common stock	-	-	-	0
Change in fair value of warrant liabilities	1,002	-4,181	-264	1,196
Change in fair value of notes payable	-	0	0	220
Issuance of shares for borrowing related costs	-	0	0	-241
Transaction costs allocated to avenue warrants, investor warrants, and hudson warrants	-	704	-	-
Accounts receivable	-82	277	-477	-1,038
Unbilled revenue	-	-	-	0
Inventory	-7	384	-8	37
Prepaid expenses	-110	-178	-228	-355
Other assets	444	315	204	-132
Accounts payable	-1,588	472	552	-2,049
Accrued expenses	308	-134	-72	-663
Deferred revenue	-154	-85	-185	-536
Proceeds from notes payable - related party	-	-	-	0
Lease liabilities	-178	-168	-84	-276
Proceeds from notes payable, net of borrowing costs	-	-	0	8,260
Net cash used in operating activities	-3,728	-2,552	-2,501	-4,867
Proceeds from issuance of common stock and warrants	-	7,558	0	3,080
Payment of issuance costs	-	642	-	-
Proceeds from notes payable	-	8,285	-	-
Payment of borrowing costs	-	47	-	-
Payments for notes payable	157	154	62	1,313
Proceeds from warrant exercises	-	534	1,992	-
Stock option exercises	156	176	555	158
Net cash provided by financing activities	-1	7,450	2,485	10,185
Effect of exchange rate changes on cash	-10	1	-13	49
Net increase in cash	-3,739	4,899	-29	5,367
Cash, beginning of period	15,394	10,495	5,157	-
Cash, end of period	11,655	15,394	10,495	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.